Jasochlor Syrup

About Jasochlor 80 mg/5 ml Syrup

Jasochlor syrup contains chloroquine phosphate, an anti-malarial medicine. It works against malaria parasites in the blood and is also used for some other conditions. Doctors decide who should take it and how much.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. 8 of them have a lower unit price than Jasochlor. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Jasochlor 80 mg/5 ml Syrup?

Jasochlor is a syrup made by Jayson Pharmaceuticals Ltd. It contains chloroquine phosphate, a medicine that acts against malaria parasites in the blood. The syrup is available in a strength of 80 mg/5 ml in a 60 ml bottle. Chloroquine is used to treat and prevent malaria, and also for some other conditions such as amoebic liver infection and certain types of arthritis and skin problems. It is important to use this medicine only under a doctor's supervision, because the dose and duration must be set by the doctor. The doctor will decide if this medicine is right for you.

Uses of Jasochlor

Jasochlor syrup is used to treat malaria and to prevent it in people travelling to areas where malaria is common. It is also used for amoebic hepatitis and amoebic abscess, and for some inflammatory conditions such as discoid and systemic lupus erythematosus and rheumatoid arthritis. Only a doctor can confirm what condition you have and whether this medicine is appropriate. Do not use it for any other purpose without medical advice.

How to use Jasochlor

Jasochlor syrup is taken by mouth. The doctor will decide the exact amount and how often to give it, based on the condition being treated, the person's age and weight, and other factors. Always follow the doctor's instructions. Do not change the amount or stop the medicine without asking the doctor. If you miss a dose, ask your doctor or pharmacist for advice. Keep the bottle closed and store it at room temperature in a dry place, away from light.

Side effects of Jasochlor

Most people tolerate chloroquine well at the doses prescribed by a doctor. Some may have headache or stomach upset. With long-term or high-dose use, side effects can be more serious and may include skin rashes, hair loss, difficulty focusing the eyes, or blurred vision. Rarely, blood problems such as low platelets or low white cells have been reported. Long-term use can rarely cause eye damage. Tell your doctor if you notice any unusual symptoms.

Safety and precautions

Before using Jasochlor syrup, tell your doctor if you have liver problems, especially if you also have porphyria, or if you drink alcohol regularly. If you need this medicine for a long time or at higher doses, your doctor may arrange eye check-ups. The use of chloroquine during pregnancy should be avoided if possible, unless the doctor decides the benefit outweighs the risk. Always ask your doctor or pharmacist before starting this medicine, especially if you are pregnant, breastfeeding, or taking other medicines.

Frequently asked questions

What is Jasochlor syrup used for and what kind of medicine is it?

Jasochlor syrup is an anti-malarial medicine. It is used to treat and prevent malaria. It is also used for amoebic liver infections and some inflammatory conditions. Only a doctor can decide if it is right for you.

What side effects should I watch for and when should I call the doctor?

Watch for headache, stomach upset, skin rash, hair loss, or vision changes such as blurred vision or trouble focusing. Call your doctor if these occur or if you feel unwell. Long-term use may require eye checks as advised by your doctor.

What do the dosage form and strength mean?

Jasochlor is a syrup, a liquid taken by mouth. The strength is 80 mg of chloroquine phosphate in each 5 ml. The doctor will decide how much syrup to give and for how long, based on your condition.

What is the price of Jasochlor syrup?

The listed price is ৳ 14.91.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.